ZIMMER BIOMET HOLDINGS, INC. (ZBH) › Cost of RevenueZIMMER BIOMET HOLDINGS, INC. (ZBH) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2007: $875.90M2008: $997.30M2009: $990.70M2010: $1.01B2016: $2.38B2017: $2.13B2018: $2.27B2019: $2.25B2020: $1.82B2021: $1.96B2022: $2.02B2023: $2.08B2024: $2.19B2025: $2.49B$2.49B2007Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$2.49B+13.8%2024$2.19B+5.2%2023$2.08B+3.2%2022$2.02B+3.0%2021$1.96B+7.5%2020$1.82B-19.0%2019$2.25B-0.8%2018$2.27B+6.5%2017$2.13B-10.5%2016$2.38B—2010$1.01B+2.2%2009$990.70M-0.7%2008$997.30M+13.9%2007$875.90M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share